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Netherton syndrome is a congenital ichthyosis asso-
ciated with erythroderma, hair shaft defects, and ato-
pic features. The mutations of the secretory serine
protease inhibitor Kazal-type 5 gene have been identi-
®ed in Netherton syndrome patients; however, the
actual physiologic substrates of the serine protease
inhibitor Kazal-type 5 proprotein are unknown, and
how the genetic defects cause characteristic skin
phenotype remains uncertain. Here, we describe the
serine protease inhibitor Kazal-type 5 gene mutations,
including two novel non-sense mutations, and geno-
type±phenotype correlation in three Netherton syn-
drome patients in two unrelated Japanese families.
Furthermore, based on the reappraisal of the struc-
ture of the serine protease inhibitor Kazal-type 5
proprotein, demonstration of the presence of
carboxypeptidase in normal keratinocytes, and the
observation of mRNA localization of the serine pro-
tease inhibitor Kazal-type 5 transcripts in the upper-
most epidermis as well as pilosebaceous units, we
propose a hypothetical model of proteolytic process-
ing of the serine protease inhibitor Kazal-type 5 pro-
protein in the epidermis and inhibitory regulation of
corneocyte desquamation by a set of serine protease
inhibitor Kazal-type 5-derived peptides. This
hypothesis is supported by the marked increase of
trypsin-like hydrolytic activity demonstrated in stra-
tum corneum samples from our Netherton syndrome
patients. The ®ndings in this study suggest that the
defective inhibitory regulation of desquamation due
to the serine protease inhibitor Kazal-type 5 gene muta-
tions may cause over-desquamation of corneocytes
in Netherton syndrome, leading to severe skin per-
meability barrier dysfunction. Key words: carboxypeptid-
ases/congenital ichthyosiform erythroderma/serine protease
inhibitors/stratum corneum trypsin-like serine protease/sub-
tilisins. J Invest Dermatol 118:436±443, 2002
I
chthyotic skin has an abnormal thickening of the stratum
corneum, the fully differentiated end product of the
epidermis. As the stratum corneum can be viewed as a
compartment, thickening of the stratum corneum is the
result of cells entering the compartment at an increased rate
(i.e., hyper-proliferation of the epidermal keratinocytes) or leaving
too slowly (i.e., increased corneocyte adhesion) or both (Frost and
Van Scott, 1966). Congenital ichthyosis can be divided into the
major primary forms affecting only the skin and ichthyosiform
syndromes associated with various systemic manifestations (Grif®ths
et al, 1998). Netherton syndrome (NS) (MIN 256500) is the most
common of the multisystem ichthyosiform syndromes, and
comprises an ichthyosis with a variable erythroderma, hair shaft
defects, and atopic features (Greene and Muller, 1985; Judge et al,
1994). Recently, mutations of the secretory serine protease inhibitor
Kazal-type 5 (SPINK5) gene were identi®ed in patients with NS
(Chavanas et al, 2000), and a detailed analysis correlating clinical
presentations and genetic defects in a large number of affected
families was reported (Sprecher et al, 2001).
The SPINK5 gene encodes a serine protease inhibitor proprotein
containing two classical Kazal-type and 13 non-Kazal-type
domains, which may be crucial for epidermal cell growth and
differentiation (Magert et al, 1999). The actual physiologic
substrates of the SPINK5 proprotein are currently unknown,
however, and consequently, how the genetic defects in the
SPINK5 gene cause characteristic skin manifestations in NS
remains to be determined.
Here we describe clinical features and the SPINK5 gene
mutations, including two novel non-sense mutations in three NS
patients in two unrelated Japanese families. Furthermore, we
propose a hypothetical model of proteolytic processing of the
SPINK5 proprotein in the epidermis and inhibitory regulation of
corneocyte desquamation by a set of SPINK5-derived peptides.
This hypothesis is supported by the increase of trypsin-like
hydrolytic activity demonstrated in stratum corneum samples
from our NS patients. The ®ndings in this study suggest that the
defective inhibitory regulation of desquamation due to the SPINK5
gene mutations may cause over-desquamation of corneocytes in
NS, leading to severe skin permeability barrier dysfunction.
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MATERIALS AND METHODS
Patients Three patients with NS in two unrelated Japanese families
were studied. The siblings (now 17 and 18 y old, respectively) in family
A were born with severe erythroderma covered with a collodion-like
membrane. They suffered from temperature instability, dehydration, and
skin infections until adolescence. Generalized exfoliative erythroderma
with pruritus and burning irritation persisted in both patients until now.
As trichorrhexis invaginata and atopic features were not apparent until
the age of 17 and 13 y, respectively, the affected siblings in this family
had been followed up with the diagnosis of nonbullous ichthyosiform
erythroderma. In contrast, the patient in family B showed a much milder
cutaneous phenotype with patchy islands of normal skin and readily
recognized ichthyosis linearis circum¯exa (Fig 1 right). Typical trichor-
rhexis invaginata, eosinophilia, and raised serum IgE levels were noted at
the age of 2 y.
Mutation analysis Blood samples for genetic analyses were collected
after obtaining informed consent from three patients and their parents.
Genomic DNA was isolated from the peripheral blood samples by
phenol±chloroform extraction using standard methods (Maniatis et al,
1989). Normal control DNA was obtained from 18 unrelated Japanese
individuals without skin disease. The SPINK5 gene is composed of 33
exons spreading over 61 kb on the distal long arm of chromosome 5q32
(EMBL accession numbers NM006846, AJ270994, AJ391230±54, and
AJ276577±80). All exons were polymerase chain reaction (PCR)-
ampli®ed using synthetic oligonucleotides with a sequence
complementary to the intronic sequences as a primer (Table I). Primers
for 6, 8, 10, 11, and 33 were as described elsewhere (Sprecher et al,
2001). PCR products were puri®ed, and were subjected to direct
nucleotide sequencing using a dye terminator cycle sequencing method
with an ABI 310 automated DNA sequencer (Applied Biosystems,
Norwalk, CT). Both sense and anti-sense strands were analyzed for each
exon.
Reverse transcription±PCR for carboxypeptidases Total RNA was
isolated from cultured normal human keratinocytes (Epidercell
NHEK(F), Kurabo, Osaka, Japan) and normal human skin with the
guanidium isothiocyanate±cesium centrifugation method. First strand
cDNA was synthesized in a total volume of 20 ml containing 2 mg of
total RNA, 0.5 mM of oligo-dT as a primer, the reverse transcription
buffer, 2 mM of deoxyribonucleoside triphosphate, 50 U of RevatraAse
reverse transcriptase (Toyobo, Osaka, Japan), and 20 U RNase inhibitor
(Toyobo). The amount of cDNA was standardized by GAPDH
ampli®cation. A 1 ml aliquot was subjected to PCR ampli®cation using
oligonucleotide primers targeting carboxypeptidase D (CPD) and
carboxypeptidase E (CPE), respectively (EMBL accession numbers
XM008645, and XM003479). Primer sequences were as follows: CPD
(5¢-GAGGAATGCAGGACTGGAACT-3¢, 5¢-CGCATTTCCATGGA-
TACCAGC-3¢; expected product size, 760 bp), and CPE (5¢-
CATCATGCCTTCCCTGAACCC-3¢, 5¢-TACGCTGTACCAAGCA-
CCACC-3¢; expected product size, 510 bp). Thirty-one cycles of PCR
was performed with the annealing temperature at 62°C. The ampli®ed
DNA samples were run on a 1.0% agarose gel, and bands were visualized
with ethidium bromide. Identity of the ampli®ed products was
con®rmed by direct sequencing.
In situ hybridization for SPINK5 mRNA The bidirectional cRNA
probes for SPINK5 mRNA were synthesized from IMAGE Consortium
clone (cDNA-ID 358027, Research Genetics, Livermore, CA) using
either T7 or SP6 RNA polymerase (Takara, Tokyo, Japan) and the DIG
Labeling Kit (Boehringer, Mannheim, Germany). The formalin-®xed
paraf®n-embedded normal human skin specimens were cut into 4 mm
sections and mounted on silane-coated glass slides. The sections were
treated with 7 mg per ml Proteinase K (Sigma, St. Louis, MO, USA) at
37°C for 20 min, treated with 0.2 M HCl, acetylated with 0.25% acetic
anhydride in 0.1 M triethanolamine, pH 8.0, dehydrated with ethanol
series, and air dried. After prehybridization with the hybridization
solution containing 50% formamide, 10% dextran sulfate, 1 3 Denhardt
(Maniatis et al, 1989), 600 mM NaCl, 0.25% sodium dodecyl sulfate, and
150 mg per ml yeast tRNA at 50°C for 2 h, each slide was allowed to
hybridize with approximately 0.5 mg per ml of the cRNA probe at 50°C
overnight. The slides were washed brie¯y in 5 3 sodium citrate/chloride
buffer at ambient temperature in 50% formamide and in 2 3 sodium
citrate/chloride buffer at 50°C for 30 min, treated with 10 mg per ml
RNase A at 37°C for 30 min and again washed once with 2 3 sodium
citrate/chloride buffer and twice with 0.2 3 sodium citrate/chloride
buffer for 20 min each at 50°C. Hybridized probes were detected with
the Nucleic Acid Detection Kit (Boehringer, Mannheim, Germany).
Figure 1. Clinical features of NS patients from two unrelated Japanese families. (a) Severe erythroderma covered with a collodion-like
membrane in the male patient of family A at 2 mo of age. (b) A much milder cutaneous phenotype with patchy islands of normal skin in the family B
patient.
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Assay of hydrolytic activity of stratum corneum samples Stratum
corneum samples were obtained from the forearm of 10 normal volunteers
(23±31 y old; ®ve males and ®ve females) and the three NS patients using
adhesive tapes such as Scotch tapes. By toluene, they were removed from
the tapes and washed until no adhesives were observed. After being
air-dried, they were weighed in order to normalize their yields of
stratum corneum. The trypsin-like hydrolytic activity was assayed using
a synthetic peptide (Boc-Phe-Ser-Arg-AMC [7-Amino-4-Methyl-
coumarin]; Peptide Institute, Osaka, Japan) as substrates (Suzuki et al,
1996). Namely, the reaction mixtures, containing 1 mg (dry weight) of
the stratum corneum, 20 ml of N,N-dimethylformamide, 0.48 ml of 0.1%
Triton X-100 (wt/wt), 0.35 ml of 0.2 mol per l Tris±HCl buffer
(pH 8.0), and 0.1 ml of 1 mmol per l substrates were incubated at 37°C
for 20±180 min. Released AMC in the reaction mixtures was measured
using a ¯uorescence spectrophotometer (FluoroScan Ascent FL,
Labsystems, Helsinki, Finland; excitation/emission = 355/460 nm). The
amount of AMC was calibrated using reference standard AMC (Molecular
Probe, Eugene, OR). The assay for each individual was triplicated.
Signi®cant difference in the activity of each patient at each time point
from those of normal volunteers was estimated using Smirnov test for
extreme value.
RESULTS
Identi®cation of the SPINK5 gene mutations and genotype±
phenotype correlation in the NS patients Mutations
Table I. PCR primers
Exon no. Primer
Annealing
temperature (°C)
Location of
primers (b)
Exon
length (bp)
Products
length (bp)
1 Forward 5¢-TAGGGTCTGTGGACTCCATCA-3¢ 63 ±241/+45 98 384
Reverse 5¢-TGAGATGTGTGGCAAGAGGCT-3¢
2 Forward 5¢-CTGGTCCAGTGCCCTTCTTTT-3¢ 61 ±178/+73 26 277
Reverse 5¢-AGGTGTTGGCCACAAACCACT-3¢
3 Forward 5¢-GGCATTCTTTGAGGGCTTTAC-3¢ 59 ±156/+143 128 427
Reverse 5¢-ATGTCAGAGTGATCTGCTCAG-3¢
4 Forward 5¢-TTTGACATGCCAGGCTAGGCT-3¢ 61 ±118/+120 73 311
Reverse 5¢-CCCTCCTAAGTTGTTGGCTTC-3¢
5 Forward 5¢-AGCTCAATGTAGCCTTCATGA-3¢ 57 ±139/+122 128 389
Reverse 5¢-ATTTAGGAATGGCTAACTCCC-3¢
7 Forward 5¢-CTGAAAACAGTGTTGTCAGCA-3¢ 52 ±64/+84 128 276
Reverse 5¢-GGATTTTATCTCTCTGCTGAG-3¢
9 Forward 5¢-GCGCAATGCAGCAAAATCCTG-3¢ 63 ±84/+61 128 273
Reverse 5¢-TCCAATCAATCTCCACTCCCC-3¢
12 Forward 5¢-CATAGCACCATACTATCCTGG-3¢ 59 ±174/+81 82 337
Reverse 5¢-GGCAAAATCTCACCCTTTAGG-3¢
13 Forward 5¢-CCTATCTCTTGGCATATGATG-3¢ 57 ±182/+141 128 451
Reverse 5¢-TGTCTCCAATCAGACAGTTTC-3¢
14 Forward 5¢-GGGTTAGGCACATCACATTCA-3¢ 59 ±127/+84 82 293
Reverse 5¢-TTAAGGAATGCACGTGTTCCC-3¢
15 Forward 5¢-TCTTGGTTGTTGGGTTCATTG-3¢ 57 ±179/+125 128 432
Reverse 5¢-TATGACACCCAAGACTGAATG-3¢
16 Forward 5¢-AATTGCTTGAACCCGGGAGGT-3¢ 63 ±145/+163 49 357
Reverse 5¢-GGACACTTCTTATCAGGACCC-3¢
17 Forward 5¢-TTCTGATTGATGACGGAAGCT-3¢ 57 ±162/+97 128 387
Reverse 5¢-ACTCACGGTCTATACTCTACA-3¢
18 Forward 5¢-AGCAAAAGCACCTCTCAGACT-3¢ 59 ±145/+212 85 442
Reverse 5¢-ATTGATCTCTCTCCTGCACGA-3¢
19 Forward 5¢-CTTTCACAGTGCCTAGTGCAG-3¢ 61 ±243/+80 128 451
Reverse 5¢-CTTCCAATGTCACCCCTCTTG-3¢
20 Forward 5¢-GCAACAGAGTGAGACACCATC-3¢ 61 ±219/+125 67 411
Reverse 5¢-ACCCCTGGACTAAATGAACCC-3¢
21 Forward 5¢-TACAGCCACCTTCTTAAGTCC-3¢ 59 ±179/+43 128 350
Reverse 5¢-CAATTCCACCATCCCACAGTA-3¢
22 Forward 5¢-AGAGAAGGCCTGCAGCATAGT-3¢ 61 ±146/+172 97 415
Reverse 5¢-CCCCAGAGCAGTGAAAATGTG-3¢
23 Forward 5¢-GCTCTTCGTTCTTCTCTGTTT-3¢ 57 ±25/+30 128 183
Reverse 5¢-TTAGACATGCCTGTTGAGAGA-3¢
24 Forward 5¢-CTTAGTGCATAATCCAGGGTC-3¢ 59 ±64/+63 73 200
Reverse 5¢-TTTGATCGCCAACTGCTGACT-3¢
25 Forward 5¢-CTGCCTGACTCTTGGAAAGAA-3¢ 59 ±95/+223 128 446
Reverse 5¢-TCCTTTCTCCTGTATTGCTCC-3¢
26 Forward 5¢-ACTCGAGAAAGTGACCCTGTC-3¢ 61 ±235/+95 97 427
Reverse 5¢-GGGACAGAGTCAGCATTTCAC-3¢
27 Forward 5¢-CGGTCAATCATGTTATCAGGT-3¢ 57 ±70/+291 128 489
Reverse 5¢-ATTTTTCCCTCAGGAGGAACT-3¢
28 Forward 5¢-GAAAGTTGATAGCATTGCCAC-3¢ 57 ±212/+79 73 364
Reverse 5¢-ATTCCCAAAGCTGGAGAAGAA-3¢
29 Forward 5¢-GGATGGATGAACGGGAGAAAA-3¢ 57 ±270/+54 128 452
Reverse 5¢-CTAAAAATGCAGTTCCCCTGC-3¢
30 Forward 5¢-GCTTAACTTCTCACTGGAAGT-3¢ 57 ±69/+100 97 266
Reverse 5¢-AAACCTCAGACCCTTCTATGA-3¢
31 Forward 5¢-ACCCCTCTTCTTGAATGCCAT-3¢ 59 ±54/+65 131 250
Reverse 5¢-TGGGTTAACACTCTAGCTGAG-3¢
32 Forward 5¢-GTGTCCTGCATGTTGGTCCTT-3¢ 61 ±84/+135 91 310
Reverse 5¢-ACCAATTCTGGGTCACCTGAC-3¢
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demonstrated in the siblings of family A with a severe phenotype
were a two-nucleotide deletion (375delAT) in exon5 directly
leading to a stop codon at codon 126 (Y126X) and a point
mutation from 1621G to T in exon 18 resulting in a stop codon
(E541X). The sequencing analysis of parents' DNA showed that
the Y126X mutant allele was inherited from the heterozygous
father, whereas the mother was a E541X heterozygote (Fig 2).
These two non-sense mutations were novel, not reported
previously (Sprecher et al, 2001). The patient in family B with
mild skin phenotype was homozygous for a C to T point mutation
at nucleotide 2368 in exon 25 generating a stop codon at codon
790 (R790X). This mutation was present in the heterozygous state
in both parents (Fig 2). The same non-sense mutation was
previously found in one family (Chavanas et al, 2000). All the
three identi®ed mutations were not detected in 18 normal
individuals. The mutation in family B is predicted to result in a
truncated protein at codon 790, which would still produce 11
potential inhibitor peptides. By contrast, the two non-sense
mutations identi®ed in family A are predicted to result in
premature termination much more upstream. The ®ndings
con®rm recently described genotype±phenotype correlation in
NS patients (Sprecher et al, 2001).
Carboxypeptidases are expressed in normal human skin and
cultured keratinocytes It is known that human epidermis
express several subtilisin-like proprotein convertase (SPC)
including furin, PACE4, PC5/PC6, PC7/8, and PC8 (Bruzzaniti
et al, 1996; Pearton et al, 2001). To examine whether
carboxypeptidases, which are necessary to activate the peptides
cleaved by SPC, are expressed in human skin, we examined the
mRNA expression of CPD and CPE by reverse transcription±PCR
using speci®c primers. The analysis showed the expression of these
two SPC-related carboxypeptidases in normal human skin as well as
in cultured keratinocytes (Fig 3).
Localization of SPINK5 transcripts in normal human
skin The in situ hybridization study showed that SPINK5
transcripts were expressed in the uppermost stratum spinosum
and stratum granulosum of the epidermis. In addition, strong
hybridization signals were also observed in hair follicle epithelium
and sebaceous glands (Fig 4).
Stratum corneum trypsin-like hydrolytic activity is
increased in NS patients and correlates with the sites of
truncation of the SPINK5 proprotein and severity of skin
lesions The trypsin-like hydrolytic activity was assayed using a
synthetic peptide as previously described (Suzuki et al, 1996). The
hydrolysis of normal control samples gradually increased in a time-
dependent manner. The hydrolytic activity of siblings in family A
was about 5-fold higher than those of controls even at 20 min. The
hydrolysis of the daughter reached a plateau at 120 min and that of
the son at 180 min, both being 66.5 nmol AMC/1 mg dry weight.
By contrast, The activity of the family B patient was only slightly
higher than those of controls within 60 min but 39.4 nmol AMC/
1 mg dry weight was hydrolyzed at 180 min, being more than
twice as much as those of controls (Fig 5). Increased trypsin-like
activity in stratum corneum samples from the patients was reduced
more than 40% by co-incubation with 1 mg leupeptin per ml, a
trypsin inhibitor (data not shown).
DISCUSSION
The SPINK5 gene encodes a 15-domain type serine protease
inhibitor initially designated as lymphoepithelial Kazal-type 5 serine
protease inhibitor (LEKTI) (Magert et al, 1999) (Fig 6a). As this
protein is a proprotein possessing a secretory signal peptide (Magert
et al, 1999), bioactive polypeptides may be derived from this
protein by limited proteolysis within the secretory pathway (Zhou
et al, 1999). In general, the ®rst cleavage of proproteins is carried
out by a family of well-known SPC that show speci®c tissue
distribution and cellular localization (Bergeron et al, 2000). SPC are
highly speci®c enzymes and typically cleave precursor proteins at
the general motif of Lys/Arg (K/R)-Xn-Lys/Arg (K/R) ¯ (n = 0,
2, 4, and 6), especially the Lys-Arg ¯ or Arg-Arg ¯ motif (Seidah
and Chretien, 1999). After the cleavage by SPC, the newly exposed
Figure 2. Mutations of the SPINK5 gene identi®ed in two NS families. The genomic sequences of sense strands and the corresponding amino
acid sequences are shown at the top of each chart. Asterisks indicate stop codons. The underlined nucleotides are mutated. (a) The siblings in family A
are compound heterozygotes of two novel non-sense mutations; a two-nucleotide deletion (375delAT) in exon 5 directly leading to a stop codon at
codon 126 (Y126X) and a point mutation from 1621G to T in exon18 resulting in a stop codon (E541X). The Y126X mutant allele was inherited
from the heterozygous father, whereas the mother was a E541X heterozygote. (b) The patient in family B was homozygous for a C to T point
mutation at nucleotide 2368 in exon 25 generating a stop codon at codon 790 (R790X). This mutation was present in the heterozygous state in both
parents.
Figure 3. The mRNA expression of carboxypeptidases in normal
skin and cultured keratinocytes. 1.0% agarose gel electrophoresis
showing ampli®ed products for CPD (761 bp), CPE (511 bp), and
GAPDH (351 bp) are visible. Mk is a 100 bp ladder.
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basic residues of the released N-terminal peptides are further
removed by carboxypeptidases and the precursors become bioactive
polypeptides (Bergeron et al, 2000). Scrutinizing the amino acid
sequence of the SPINK5 proprotein, we noticed that there actually
are a number of Lys/Arg(K/R)-Xn-Lys/Arg(K/R) motifs that
could be a target of SPC cleavage (Fig 6b). At present, seven
mammalian SPC (furin/PACE, PC2, PC1/PC3, PACE4, PC4,
PC5/PC6, and PC7/8/LPC) and two SPC-related carboxypepti-
dases (CPD and CPE) are known (Bergeron et al, 2000). In human
epidermis, the expression of furin, PACE4, PC5/PC6, and PC7/8
(Pearton et al, 2001) as well as PC8 (Bruzzaniti et al, 1996) was
reported but the existence of CPD and CPE is not yet known. Our
reverse transcription±PCR analysis using primers speci®c to CPD
and CPE con®rmed the expression of these two SPC-related
carboxypeptidases in normal human skin as well as in cultured
keratinocytes (Fig 3). Thus, human keratinocytes, like other cell
types (Bergeron et al, 2000), express a distinct cocktail of SPC as
well as carboxypeptidases, which could mediate proteolysis of the
SPINK5 proprotein [and possibly other proproteins in the epider-
mis such as propiomelanocortin (Teofoli et al, 1997), pro®brillin
(Haynes et al, 1997), and pro®llagrin (Pearton et al, 2001)]. Such
proteolysis of the SPINK5 proprotein would give rise to at least 14
polypeptides, each possessing one or a few serine protease inhibitor
domains.
Although the expression of SPINK5 mRNA in cultured human
keratinocytes was shown (Chavanas et al, 2000), the exact
localization of SPINK5 transcripts within the epidermis was
unknown. Our in situ hybridization study showed that SPINK5
transcripts were expressed in the uppermost stratum spinosum and
stratum granulosum of the epidermis as well as in hair follicles and
sebaceous glands (Fig 4). This localization strongly suggests that the
inhibitor peptides derived from the SPINK5 proprotein may target
two known serine proteases in the epidermis, stratum corneum
trypsin-like enzyme (SCTE) (Brattsand and Egelrud, 1999) and
stratum corneum chymotrypsin-like enzyme (SCCE) (Hansson et
al, 1994), both of which are expressed in stratum granulosum and
stratum corneum as well as in the pilosebaceous units (Ekholm et al,
2000). In the interfollicular epidermis, the presence of precursors as
well as active forms of SCTE and SCCE in normal super®cial
stratum corneum and the activity of both enzymes over a broad
range of pH values suggest their role in desquamation (Ekholm et al,
2000), perhaps by the degradation of desmoglein-1, a cell±cell
adhesion molecule essential for corneocyte cohesion (Suzuki et al,
1996).
Figure 4. In situ hybridization for SPINK5 mRNA in normal
skin. Anti-sense (top and bottom left) and sense (bottom right) cRNA
probes were hybridized to normal skin tissue. The anti-sense probe alone
hybridized to the uppermost stratum spinosum and stratum granulosum
of the epidermis as well as in hair follicles (top, 3 40; bottom left and
right, 3 200).
Figure 5. Trypsin-like hydrolytic activity in the stratum corneum
samples from NS patients and normal control subjects. The
hydrolysis of normal controls indicated as the mean 6 SD (n = 10) (s±
s) was gradually increased in a time-dependent manner. The SD for
20±60 min was smaller than the size of circles. The hydrolytic activity of
patients was indicated as the mean 6 SEM of triplicated assay, whereas
SEM were within the size of symbols. *p < 0.01; the value was
signi®cantly different from the mean of normal controls (Smirnov test for
extreme value). The hydrolytic activity of siblings in family A (d±d and
j±j) was about 5-fold higher than those of controls even at 20 min.
The hydrolysis of the daughter (d) reached a plateau at 120 min and
that of the son (j) at 180 min, both being 66.5 nmol AMC per 1 mg
dry weight. The activity of the family B patient (m±m) was only slightly
higher than those of controls within 60 min but 39.4 nmol AMC per
1 mg dry weight was hydrolyzed at 180 min, being more than twice as
much as those of controls.
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Based on these ®ndings, we propose a model for proteolytic
cleavage of the SPINK5 proprotein within the epidermis and the
desquamation regulation by the cleaved peptides with the
inhibitory action against stratum corneum serine proteases
(Fig 7a). The defective inhibitory regulation of SPINK5-derived
peptides due to the gene mutations in NS patients would result in
increased protease activity in the stratum corneum, accelerate
degradation of desmoglein-1, and ®nally lead to the over-
desquamation of corneocytes (Fig 7b). Co-localization of
SPINK5 transcripts with SCTE/SCCE proteins in hair follicles
suggests that the regulation of these proteases activity by the
SPINK5-derived inhibitors may also affect hair growth and
morphogenesis. As topical trypsin treatment following depilation
induces apoptotic cell death at the follicular papilla resulting in
delayed hair growth in mice (Seiberg et al, 1997), overactivation of
SCTE/SCCE in hair follicles due to the defective inhibitory
regulation of SPINK5-derived peptides may cause characteristic
hair shaft abnormalities in NS.
To test this hypothesis, we measured the hydrolytic activity of
stratum corneum samples in our NS patients from two families with
different SPINK5 mutations with different cutaneous phenotypes
(Fig 5). As expected, the trypsin-like activity in the stratum
corneum samples was markedly increased in all three NS patients
compared with normal controls, clearly indicating that serine
proteases in the stratum corneum are over-reacting in NS patients,
perhaps due to the defective inhibitory regulation caused by
SPINK5 mutations. Furthermore, the degree of increase in trypsin-
like activity was correlated with the severity of skin lesions and the
sites of truncation of the SPINK5 proprotein; the siblings in family
A with severe persistent erythroderma and upstream translation
termination mutations showed a 5-fold increase compared with
normal controls, whereas the patient in family B with a mild
cutaneous phenotype and mutation near 3¢ end showed 3-fold
increase.
All 26 mutations in the SPINK5 gene in NS patients identi®ed
so far (Chavanas et al, 2000; Sprecher et al, 2001) and two novel
mutations found in our patients are non-sense, frameshift, and
altered splicing mutations. These mutations in the SPINK5 gene
would result in the production of truncated SPINK5 proproteins
containing fewer inhibitory domains. It is now clear that patients
with mild skin lesions have non-sense mutations downstream near
the 3¢ end, whereas severe erythrodermic patients have early
premature termination mutations (Sprecher et al, 2001). Our
hypothetical model of the role of the SPINK5 proprotein in the
skin and their defects in NS patients (Fig 7) explains the differences
in clinical severity and trypsin-like hydrolytic activity of stratum
corneum samples between our two families (Figs 1 and 5). It
should be examined in future studies whether trypsin-like
hydrolytic activity of stratum corneum correlates with genotypes
and phenotypes in additional families. If correlation was con®rmed,
simple measurements of the hydrolytic activity in stratum corneum
would help to predict the affected exons in NS patients.
Although NS is classi®ed as one of the ichthyosiform syndromes,
temperature instability, hypernatraemic dehydration, and frequent
skin infections that commonly complicate in neonatal periods are
unique to this disease not observed in other ichthyoses (Greene and
Muller, 1985; Judge et al, 1994). Furthermore, therapeutic
problems reported in NS patients such as the propensity to develop
iatrogenic Cushing's syndrome by topical steroids (Smith et al,
1995), signi®cant absorption of topical tacrolimus (Allen et al,
2001), and aggravation of skin lesions by retinoid therapy (Judge
et al, 1994) suggest the severe skin permeability barrier dysfunction
Figure 6. Reorganized amino acid sequences of SPINK5 modi®ed from Magert et al (Magert et al, 1999) emphasizing potential SPC
cleavage sites. A signal peptide (pink letters in small size), There are a total of 15 serine-protease-inhibitory domains containing Cys±Cys bound loops
in the proprotein. Thirteen domains are non Kazal-type with four cysteins (a, b, light brown boxes) and the remaining two are Kazal-type with six
cysteins (a, b, yellow boxes), which are encoded by odd number exons (from exon 3 to exon 31). Kazal-type domains (yellow boxes) are also encoded
in part by exon 6 and exon 32. This SPINK5 proprotein is suggested to be further processed because there are a number of consensus sequences for
possible cleavage sites by SPC (K/R-Xn-K/R ¯ where X is any amino acid and n = 0, 2, 4, or 6; marked in red). R-Xn-KR ¯ is the most potent
consensus sequence for furin, which is known to be expressed in the stratum granulosum of the skin (Bergeron et al, 2000). These potential cleavage
sites (a, ¯; b, red letters) are encoded by even number exons. A putative cleavage site cannot be found between the second and third domains, and,
thus, the SPINK5 proprotein is suggested to be cleaved into at least 14 polypeptides. The basic amino acids at the C-terminal of the cleaved
polypeptides are further removed by carboxypeptidases and activated as serine protease inhibitors. Although the activation mechanism for the Kazal-
type domain is yet unknown, cleavage by SPC alone appears to be suf®cient for activation because SPINK1 with Kazal-type domains are known to be
activated by single cleavage (Witt et al, 2000). The peptides indicated in underlined blue letters (b) were isolated from human blood ®ltrate, and one
was shown to have an inhibitory effect on trypsin (Magert et al, 1999).
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in NS (Fartasch et al, 1999). Recent electron microscopic
observation in the skin of erythrodermic NS shows premature
secretion of lamellar body contents and incomplete lipid processing
in the intercellular space of stratum corneum, which could explain
impaired permeability barrier (Fartasch et al, 1999). Cutaneous
barrier function is one factor that regulates epidermal DNA
synthesis, and the barrier perturbation such as by tape-stripping
increases epidermal DNA synthesis (Proksch et al, 1991). Similarly,
over-desquamation of corneocytes due to the increased protease
activity in the stratum corneum of NS patients is likely to cause
increased DNA synthesis and rapid epithelial turnover, which may
lead to the reduced lipid content in the stratum corneum and/or
altered composition from incomplete lipid processing. Thus, there
seems to be a vicious cycle of barrier disruption and rapid epidermal
turnover in NS skin. Our model of desquamation regulation by
stratum corneum proteases and the SPINK5-derived inhibitors
explains very nicely why this vicious cycle is easily triggered in NS.
Furthermore, this model of skin barrier dysfunction might also help
to understand the pathogenesis of atopic dermatitis that is often
associated with NS (Smith et al, 1995), and is also characterized by
skin permeability barrier dysfunction (Ogawa and Yoshiike, 1993).
In conclusion, we suggest that NS may not be an ichthyosis
characterized by the retention of thick adherent scales (Frost and
Van Scott, 1966) but a disease of over-desquamation causing severe
Figure 7. A model for desquamation regulation by the SPINK5 proprotein in normal individuals and NS patients. (a) In normal skin, the
®rst cleavage of SPINK5-propotein is carried out at the Lys/Arg (K/R)-Xn-Lys/Ser (K/R) (n = 0, 2, 4, and 6) motif by a cocktail of SPC expressed
in keratinocytes. Cleaved peptides are further processed by carboxypeptidases, and a number of peptides with activated Cys±Cys inhibitory domains are
generated. These bioactive peptides are inhibitors of stratum corneum serine proteases such as SCTE and SCCE that may degrade intercellular
desmoglein-1 and desquamate super®cial corneocytes. (b) In NS patients, translation termination mutations in the SPINK5 gene result in the
production of truncated proprotein containing fewer inhibitory domains. This leads to the overactivation of stratum corneum serine proteases,
overdegradation of desmoglein-1, and ®nally overdesquamation of corneocytes.
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skin permeability barrier dysfunction. Although there is no effective
treatment currently available for NS patients, the defective
inhibitory activity against stratum corneum serine proteases
demonstrated in this study may suggest a novel therapeutic
approach for NS patients by topical treatment with protease
inhibitors. A preliminary clinical trial is now underway in our
patients.
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